• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症起源细胞。

Cells of origin in cancer.

机构信息

Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.

出版信息

Nature. 2011 Jan 20;469(7330):314-22. doi: 10.1038/nature09781.

DOI:10.1038/nature09781
PMID:21248838
Abstract

Both solid tumours and leukaemias show considerable histological and functional heterogeneity. It is widely accepted that genetic lesions have a major role in determining tumour phenotype, but evidence is also accumulating that cancers of distinct subtypes within an organ may derive from different 'cells of origin'. These cells acquire the first genetic hit or hits that culminate in the initiation of cancer. The identification of these crucial target cell populations may allow earlier detection of malignancies and better prediction of tumour behaviour, and ultimately may lead to preventive therapies for individuals at high risk of developing cancer.

摘要

实体瘤和白血病都表现出相当大的组织学和功能异质性。人们普遍认为,遗传病变在决定肿瘤表型方面起着主要作用,但越来越多的证据表明,同一器官内不同亚型的癌症可能来自不同的“起源细胞”。这些细胞获得了导致癌症起始的第一个或多个遗传打击。鉴定这些关键靶细胞群体可能有助于更早地发现恶性肿瘤,并更好地预测肿瘤的行为,最终可能为癌症高危个体提供预防性治疗。

相似文献

1
Cells of origin in cancer.癌症起源细胞。
Nature. 2011 Jan 20;469(7330):314-22. doi: 10.1038/nature09781.
2
Stem-cell origin of metastasis and heterogeneity in solid tumours.实体瘤转移的干细胞起源及异质性
Lancet Oncol. 2002 Aug;3(8):508-13. doi: 10.1016/s1470-2045(02)00820-3.
3
Tracing the cellular origin of cancer.追踪癌症的细胞起源。
Nat Cell Biol. 2013 Feb;15(2):126-34. doi: 10.1038/ncb2657. Epub 2013 Jan 20.
4
Tumour heterogeneity and cancer cell plasticity.肿瘤异质性和癌细胞可塑性。
Nature. 2013 Sep 19;501(7467):328-37. doi: 10.1038/nature12624.
5
Cancer heterogeneity--a multifaceted view.癌症异质性——多角度的观察。
EMBO Rep. 2013 Aug;14(8):686-95. doi: 10.1038/embor.2013.92. Epub 2013 Jul 12.
6
Stem-cell hierarchy in skin cancer.皮肤癌中的干细胞层级结构。
Nat Rev Cancer. 2003 Jun;3(6):434-43. doi: 10.1038/nrc1095.
7
Revisiting the dynamic cancer stem cell model: Importance of tumour edges.重新审视动态癌症干细胞模型:肿瘤边缘的重要性。
Crit Rev Oncol Hematol. 2018 Nov;131:35-45. doi: 10.1016/j.critrevonc.2018.08.004. Epub 2018 Aug 28.
8
Stem cell origin of cancer and differentiation therapy.癌症的干细胞起源与分化治疗
Crit Rev Oncol Hematol. 2004 Jul;51(1):1-28. doi: 10.1016/j.critrevonc.2004.04.007.
9
Cellular Mechanisms Underlying Intertumoral Heterogeneity.肿瘤间异质性的细胞机制
Trends Cancer. 2015 Sep;1(1):15-23. doi: 10.1016/j.trecan.2015.07.003. Epub 2015 Sep 28.
10
Stem cells and cancer: a deadly mix.干细胞与癌症:致命组合。
Cell Tissue Res. 2008 Jan;331(1):109-24. doi: 10.1007/s00441-007-0510-7. Epub 2007 Oct 16.

引用本文的文献

1
Learning the cellular origins across cancers using single-cell chromatin landscapes.利用单细胞染色质图谱了解癌症的细胞起源。
Nat Commun. 2025 Sep 17;16(1):8301. doi: 10.1038/s41467-025-63957-3.
2
Identification of malignant cells in single-cell transcriptomics data.单细胞转录组学数据中恶性细胞的识别。
Commun Biol. 2025 Aug 22;8(1):1264. doi: 10.1038/s42003-025-08695-4.
3
[Initial diagnosis of Waldenström's macroglobulinemia-Venous prestasis leads to unexpected discovery of the life-threatening systemic disease].[华氏巨球蛋白血症的初步诊断——静脉淤滞导致危及生命的全身性疾病的意外发现]

本文引用的文献

1
Subtypes of medulloblastoma have distinct developmental origins.髓母细胞瘤亚型具有不同的发育起源。
Nature. 2010 Dec 23;468(7327):1095-9. doi: 10.1038/nature09587. Epub 2010 Dec 8.
2
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.Claudin-low 型乳腺癌的表型和分子特征。
Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2.
3
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.BRCA1 基底样乳腺癌起源于腔上皮祖细胞,而不是基底干细胞。
Ophthalmologie. 2025 Aug 12. doi: 10.1007/s00347-025-02300-z.
4
Applying multilevel selection to understand cancer evolution and progression.应用多层次选择来理解癌症的演变和进展。
PLoS Biol. 2025 Jul 18;23(7):e3003290. doi: 10.1371/journal.pbio.3003290. eCollection 2025 Jul.
5
Reactivation of Multipotency in the Mammary Gland - a Ripple in the Pond and a Turn of the Tide.乳腺多能性的重新激活——如池中涟漪,似潮流转向
J Mammary Gland Biol Neoplasia. 2025 Jul 17;30(1):11. doi: 10.1007/s10911-025-09586-4.
6
Cell identity and 5-hydroxymethylcytosine.细胞身份与5-羟甲基胞嘧啶
Epigenetics Chromatin. 2025 Jun 19;18(1):36. doi: 10.1186/s13072-025-00601-w.
7
Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis.体外模拟肿瘤微环境复杂性:球体作为生理相关肿瘤模型及其分析策略
Cells. 2025 May 17;14(10):732. doi: 10.3390/cells14100732.
8
Death-ision: the link between cellular resilience and cancer resistance to treatments.死亡决定:细胞恢复力与癌症治疗抗性之间的联系。
Mol Cancer. 2025 May 15;24(1):144. doi: 10.1186/s12943-025-02339-1.
9
Tissue mechanics in tumor heterogeneity and aggression.肿瘤异质性与侵袭中的组织力学
Trends Cancer. 2025 Aug;11(8):806-824. doi: 10.1016/j.trecan.2025.04.004. Epub 2025 Apr 29.
10
Microrobotic Swarms for Cancer Therapy.用于癌症治疗的微型机器人集群
Research (Wash D C). 2025 Apr 29;8:0686. doi: 10.34133/research.0686. eCollection 2025.
Cell Stem Cell. 2010 Sep 3;7(3):403-17. doi: 10.1016/j.stem.2010.07.010.
4
Identification of a cell of origin for human prostate cancer.鉴定人类前列腺癌的起源细胞。
Science. 2010 Jul 30;329(5991):568-71. doi: 10.1126/science.1189992.
5
Cross-species genomics matches driver mutations and cell compartments to model ependymoma.跨物种基因组学将驱动突变和细胞区室相匹配,以建立室管膜瘤模型。
Nature. 2010 Jul 29;466(7306):632-6. doi: 10.1038/nature09173. Epub 2010 Jul 18.
6
Primary tumor genotype is an important determinant in identification of lung cancer propagating cells.原发肿瘤基因型是鉴定肺癌增殖细胞的重要决定因素。
Cell Stem Cell. 2010 Jul 2;7(1):127-33. doi: 10.1016/j.stem.2010.05.021.
7
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.奥拉帕利治疗携带 BRCA1 或 BRCA2 突变的晚期乳腺癌患者的疗效:一项概念验证试验。
Lancet. 2010 Jul 24;376(9737):235-44. doi: 10.1016/S0140-6736(10)60892-6. Epub 2010 Jul 6.
8
Control of mammary stem cell function by steroid hormone signalling.甾体激素信号对乳腺干细胞功能的调控。
Nature. 2010 Jun 10;465(7299):798-802. doi: 10.1038/nature09027. Epub 2010 Apr 11.
9
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis.通过针对 APC 缺陷细胞的凋亡来预防结直肠癌。
Nature. 2010 Apr 15;464(7291):1058-61. doi: 10.1038/nature08871. Epub 2010 Mar 28.
10
DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1.DNA 聚合酶作为 MSH2 或 MLH1 蛋白缺陷型癌症的潜在治疗靶点。
Cancer Cell. 2010 Mar 16;17(3):235-48. doi: 10.1016/j.ccr.2009.12.046.